(Summary: The Overlooked Link Between Vitamin D and GI Health)
Vitamin D Deficiency Deserves More Attention — But Not for the Heart
(Summary: The Overlooked Link Between Vitamin D and GI Health)
Available under the View Online section labeled “BEST OF 2025 SO FAR”
Key Concepts
1. Vitamin D is crucial not only for bone health but also for gut health and immune regulation.
2. Low vitamin D levels are associated with increased risk of:
• Inflammatory Bowel Disease (IBD)
• Diverticulitis
• Colorectal cancer
• Liver disease (particularly in metabolic liver conditions)
3. Mechanisms of Action:
• Supports immune function in the gut via vitamin D receptors (VDRs)
• Balances the gut microbiome
4. Impact on the Gut Microbiome:
• Vitamin D deficiency disrupts microbial diversity
• Supplementation can enhance microbial stability and diversity
Conditions Strongly Linked to Vitamin D Deficiency
5. Diverticulitis:
• More common in low-sunlight areas
• Deficiency is associated with higher hospitalization and complications
6. Colorectal Cancer:
• Low vitamin D = higher incidence and worse prognosis
• Higher vitamin D levels may offer protective effects, possibly via DNA repair mechanisms
7. Inflammatory Bowel Disease (IBD):
• Common deficiency in both Crohn’s and ulcerative colitis (35–100%)
• Low levels are linked to greater disease activity, surgery, poor response to therapy
• Supplementation may reduce relapse rates (though evidence remains limited)
8. Liver Disease (especially MASLD):
• Deficiency is prevalent in fatty liver linked to metabolic syndrome
• Vitamin D may reduce fat accumulation and fibrosis in the liver
Supplementation & Testing Guidance
9. Form of Supplement:
• Vitamin D3 (animal-based) is more effective than D2 (plant-based)
10. Safe Dosage:
• Up to 2000 IU/day of D3 is safe and effective for most adults
11. Targeted Use Recommended For:
• Adults ≥75 years
• Individuals with malabsorption, osteoporosis, or diabetes
• Children and adolescents aged 1–18 years
12. Testing:
• Measurement of the active form (1,25(OH)₂D) may provide more accurate assessment in certain patients
Bottom Line
13. Vitamin D deficiency is widespread, especially among Black and Hispanic populations
14. Strong links exist between deficiency and GI inflammatory/neoplastic diseases
15. Despite general guideline caution, testing or supplementation should be considered in high-risk GI patients as part of risk reduction and disease management
16. AHA/ACC and ESC positions on Vitamin D and Cardiovascular Prevention:
• The AHA/ACC and ESC reviewed available evidence—including the VITAL trial and other large RCTs—and concluded that vitamin D supplementation does not prevent cardiovascular disease.
• Current guidelines on cardiovascular disease prevention in clinical practice (as of ESC 2021 and ACC/AHA 2019–2022) state that vitamin D should not be used for cardiovascular protection in the general population.
• Supplementation is appropriate only to address clinically proven deficiency, particularly for musculoskeletal health or in high-risk deficiency settings.
About the Author:
Dr. David A. Johnson is a distinguished academic gastroenterologist currently serving as Professor of Medicine and Chief of Gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. He is a former President of the American College of Gastroenterology (ACG) and has long been recognized for his leadership in clinical practice, national guideline development, and physician education